August 5, 2022
Treatment Approaches for Advanced Hepatocellular Carcinoma: Insight From the 2022 Gastrointestinal Cancers Symposium BookmarkGeorge Lundberg, MD
In this article for Cancer Therapy Advisor, Dr. Shaalan Beg shares updates from the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium on treatments for advanced hepatocellular carcinoma.
January 26, 2021
Behind the Scenes at Cancer Commons: Working with PatientsWith: Emma Shtivelman, PhD
Cancer Commons helps advanced cancer patients identify and access their best-possible treatments. Here, our Curious Dr. George asks Chief Scientist Emma Shtivelman, PhD, for an inside look at how she helps the people who turn to us for guidance. Curious Dr. George: As Chief Scientist at Cancer Commons for many years, you have helped thousands of patients with advanced cancer to better understand their… Read more »
December 4, 2020
What Is a Cancer Commons Options Report?With: Lola Rahib, PhD
As a Cancer Commons Scientist, Lola Rahib, PhD, helps cancer patients and caregivers navigate treatment. Some of these patients receive a Cancer Commons Options Report. Here, our Curious Dr. George asks Dr. Rahib to share what goes into each Options Report. Curious Dr. George: Cancer Commons provides advanced cancer patients who seek information with additional options for them to consider, all free of charge. What does… Read more »
- April 2, 2020
February 22, 2020
‘Fail First’ No More: Pennsylvania Moves to Expand Coverage of Treatments for Advanced Cancers BookmarkGeorge Lundberg, MD
Article from The Philadelphia Inquirer curated by Editor in Chief George Lundberg, MD, who notes:
A new Pennsylvania law requires insurance coverage for use of FDA-approved best drugs first, rather than only after failing with a cheaper alternative.
Go to full article published by The Philadelphia Inquirer.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.